Rigel to Present at the 2026 RBC Capital Markets Global Healthcare Conference

B SOUTH SAN FRANCISCO, Calif., May 14, 2026 /PRNewswire/ — Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer,…
posteditor
posteditor
Articles: 17424

Other News